These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
890 related articles for article (PubMed ID: 26089185)
1. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS). Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185 [TBL] [Abstract][Full Text] [Related]
2. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome. Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005 [TBL] [Abstract][Full Text] [Related]
3. [Drug reaction with eosinophilia and systemic symptoms]. Tehrany YA; Laffitte E; Grosgurin O; Spoerl D Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323 [TBL] [Abstract][Full Text] [Related]
4. [The major SCAR syndromes]. Piérard GE; Lesuisse M; Piérard-Franchimont C Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836 [TBL] [Abstract][Full Text] [Related]
5. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475 [TBL] [Abstract][Full Text] [Related]
6. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting. Liccioli G; Mori F; Parronchi P; Capone M; Fili L; Barni S; Sarti L; Giovannini M; Resti M; Novembre EM Clin Exp Allergy; 2020 Jan; 50(1):61-73. PubMed ID: 31608511 [TBL] [Abstract][Full Text] [Related]
7. [Severe delayed drug hypersensitivity reactions]. Maniu CM; Buss G; Feldmeyer L; Spertini F; Ribi C Rev Med Suisse; 2013 Apr; 9(382):803-4, 806-11. PubMed ID: 23667969 [TBL] [Abstract][Full Text] [Related]
8. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS. Darlenski R; Kazandjieva J; Tsankov N Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. Romano A; Caubet JC J Allergy Clin Immunol Pract; 2014; 2(1):3-12. PubMed ID: 24565763 [TBL] [Abstract][Full Text] [Related]
10. Treatments for Severe Cutaneous Adverse Reactions. Cho YT; Chu CY J Immunol Res; 2017; 2017():1503709. PubMed ID: 29445753 [TBL] [Abstract][Full Text] [Related]
11. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study. Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788 [TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome. Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483 [TBL] [Abstract][Full Text] [Related]
13. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Barbaud A; Collet E; Milpied B; Assier H; Staumont D; Avenel-Audran M; Grange A; Amarger S; Girardin P; Guinnepain MT; Truchetet F; Lasek A; Waton J; Br J Dermatol; 2013 Mar; 168(3):555-62. PubMed ID: 23136927 [TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Atanasković-Marković M; Medjo B; Gavrović-Jankulović M; Ćirković Veličković T; Nikolić D; Nestorović B Pediatr Allergy Immunol; 2013 Nov; 24(7):645-9. PubMed ID: 24028417 [No Abstract] [Full Text] [Related]
16. Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020. Tee CT; Abdullah NH; Kristummoonthy P; Lee CS Med J Malaysia; 2022 Jul; 77(4):409-414. PubMed ID: 35902928 [TBL] [Abstract][Full Text] [Related]
17. Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions. Orime M J Immunol Res; 2017; 2017():6928363. PubMed ID: 29226159 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions. Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Lymphocyte Transformation Test Results in Patients with Delayed Hypersensitivity Reactions following the Use of Anticonvulsant Drugs. Karami Z; Mesdaghi M; Karimzadeh P; Mansouri M; Taghdiri MM; Kayhanidoost Z; Jebelli B; Shekarriz Foumani R; Babaie D; Chavoshzadeh Z Int Arch Allergy Immunol; 2016; 170(3):158-62. PubMed ID: 27560351 [TBL] [Abstract][Full Text] [Related]
20. Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options. Paulmann M; Mockenhaupt M Curr Pharm Des; 2016; 22(45):6852-6861. PubMed ID: 27779083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]